Anzeige
Mehr »
Mittwoch, 24.06.2026 - Börsentäglich über 12.000 News
Die 0,61-CAD-Uranaktie, die den Giganten hinterherjagt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
940 Leser
Artikel bewerten:
(1)

Kline & Company: NEWS: Kline Analysis: Will High-Growth Projections for Biologicals be Impended by COVID-19?

PARSIPPANY, NJ, June 01, 2020 (GLOBE NEWSWIRE) -- Determining how the global pandemic will alter the landscape of their industries is now the central question of all businesses. In the past decade, the agrochemical industry has been experiencing a boom in the use of biological-based ingredients for biopesticides as well as biostimulant and biofertilizer markets, steadily progressing into double-digit figures. But what will happen next?

Due to various societal pressures such as the demand for safer foods and the protection of workers' health, a spotlight was put on the chemicals used in crop production. More research on chemical residues and toxicity levels have led to bans on some of the leading active ingredients used for crop protection. Neonicotinoids, and some organophosphate ingredients, have already been withdrawn from use, while the herbicide glyphosate remains a hotly and widely publicized issue of contention. Biological ingredients are the natural choice for closing in these market gaps and improving consumer perception and trust.

In Kline's biologicals series covering the global biopesticides market, as well as the global biostimulants and the biofertilizer market, we analyze the current situation of these industries in key country markets. While the biopesticides market is more regulated and defined, the biostimulant and biofertilizer industry is still lagging. Most countries do not have a clear definition of the biological aspect of plant health. At best, regulations are only for fertilizer products and their composition allowance for nutrient contents. This leads to many biostimulants being categorized under several different names, including biofertilizer, soil conditioners, soil amendments, soil enhancers, and plant tonics. To rectify this, the European Union Commission has announced plans to amend the EU fertilizer regulation. This regulation will help to clearly define biostimulants products, a move that will help develop and improve the market sector.

Kline forecasts the biostimulant and biofertilizer industry to grow by a CAGR of 9.5% over the next five years. Likewise, the global biopesticides industry is forecast to grow by a CAGR of 9.7% over the same period. Both market sectors anticipate high growth and signal a big shift for the agrochemical industry.

It is still too early to determine whether the current pandemic situation will affect such positive projections, as it will take a longer time for the full effects to be seen. However, leading agrochemical manufacturers have already made many investments toward developing their biologicals portfolios. Moreover, in the past five years, there has been a number of mergers and acquisitions among top-tiered agrochemical companies for the purpose of connecting research and technology capabilities and developing novel biological products for the industry. In the wake of the economic downturn caused by COVID-19, it is likely this development of new products may be decelerated, as companies will look to reduce risky spending.

The focus of such companies can shift to promoting current product portfolios to further grow sales, as opposed to introducing new products, a process which needs time to develop farmer trust in efficacy. However, C-19 has highlighted the benefits of rising technologies such as drone applications as opposed to farm labor, which could see more investments toward Precision Agricultural systems. Many existing drone companies have already tested and are using biological ingredients for applications, which could help keep the growth trend positive.

Another benefit that could curry favor for biological ingredients is that while many chemical products need to be imported across the world, it is entirely possible for many countries to begin to develop biological inputs domestically. Ingredients such as botanical extracts, humic substances, fungi, and bacteria have the potential to be developed through some countries' internal laboratory resources and can help develop its domestic supply.

To learn more about this promising market, REGISTERfor Kline's Key Insights into Biopesticides and Biostimulants Markets webinar.

Kline's Biostimulants and Biofertilizers: Global Overview of the Market and Usereport covers 10 countries, 40 country crop segments, 150 companies, and more than 100 active ingredients. It includes technology, product descriptions, company profiles, crop targets, and, most importantly, an outlook and product category forecast for each country and market segment covered.

About Kline

Kline is a worldwide consulting and research firm dedicated to providing the kind of insight and knowledge that helps companies find a clear path to success. The firm has served the management consulting and market research needs of organizations in the agrochemicals, chemicals, materials, energy, life sciences, and personal care products industries for more than 60 years. For more information, visit www.KlineGroup.com.

Attachment

  • WEBINAR-Biopesticides_Biostimulants (https://ml.globenewswire.com/Resource/Download/72a6bb93-2afd-4083-8369-6fc8885fcee9)
© 2020 GlobeNewswire (Europe)
SpaceX-Hype zu teuer – Diese 5 Aktien bieten bessere Chancen
Raumfahrt-Aktien gehören aktuell zu den heißesten Wetten an den Börsen. Spätestens mit dem spektakulären Börsengang von SpaceX ist der Sektor endgültig im Fokus der Anleger angekommen. Fantasien rund um Satellitenkommunikation, Rechenzentren im All und neue Geschäftsmodelle treiben die Kurse immer weiter nach oben.

Doch während die Begeisterung steigt, werden auch die Risiken größer. Viele Space-Start-ups sind inzwischen extrem hoch bewertet, arbeiten noch nicht profitabel und hängen stark von stetigem Kapitalzufluss ab. Schon kleine Rückschläge könnten die ambitionierten Wachstumspläne ins Wanken bringen.

Für Anleger, die vom Boom der Raumfahrt profitieren wollen, lohnt sich daher ein Perspektivwechsel. Statt auf überhitzte Pure Plays zu setzen, rücken etablierte Konzerne in den Fokus – Unternehmen mit jahrzehntelanger Erfahrung, stabilen Cashflows und engen Verbindungen zu Raumfahrtagenturen wie NASA und ESA.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau dieses Profil erfüllen: solide bewertet, operativ stark und bestens positioniert, um langfristig vom Space-Boom zu profitieren.

Jetzt den kostenlosen Report sichern – bevor der Markt die versteckten Gewinner entdeckt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.